• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在竞争风险时的失效时间分析。

The analysis of failure times in the presence of competing risks.

作者信息

Prentice R L, Kalbfleisch J D, Peterson A V, Flournoy N, Farewell V T, Breslow N E

出版信息

Biometrics. 1978 Dec;34(4):541-54.

PMID:373811
Abstract

Distinct problems in the analysis of failure times with competing causes of failure include the estimation of treatment or exposure effects on specific failure types, the study of interrelations among failure types, and the estimation of failure rates for some causes given the removal of certain other failure types. The usual formation of these problems is in terms of conceptual or latent failure times for each failure type. This approach is criticized on the basis of unwarranted assumptions, lack of physical interpretation and identifiability problems. An alternative approach utilizing cause-specific hazard functions for observable quantities, including time-dependent covariates, is proposed. Cause-specific hazard functions are shown to be the basic estimable quantities in the competing risks framework. A method, involving the estimation of parameters that relate time-dependent risk indicators for some causes to cause-specific hazard functions for other causes, is proposed for the study of interrelations among failure types. Further, it is argued that the problem of estimation of failure rates under the removal of certain causes is not well posed until a mechanism for cause removal is specified. Following such a specification, one will sometimes be in a position to make sensible extrapolations from available data to situations involving cause removal. A clinical program in bone marrow transplantation for leukemia provides a setting for discussion and illustration of each of these ideas. Failure due to censoring in a survivorship study leads to further discussion.

摘要

在分析具有竞争失效原因的失效时间时,存在一些独特的问题,包括估计治疗或暴露对特定失效类型的影响、研究失效类型之间的相互关系,以及在去除某些其他失效类型的情况下估计某些原因的失效率。这些问题通常是根据每种失效类型的概念性或潜在失效时间来形成的。这种方法因存在无端假设、缺乏物理解释和可识别性问题而受到批评。本文提出了一种替代方法,该方法利用针对可观测数量(包括随时间变化的协变量)的特定原因风险函数。特定原因风险函数被证明是竞争风险框架中的基本可估计量。本文提出了一种方法,用于研究失效类型之间的相互关系,该方法涉及估计将某些原因的随时间变化的风险指标与其他原因的特定原因风险函数相关联 的参数。此外,本文认为,在指定原因去除机制之前,去除某些原因时的失效率估计问题并未得到妥善解决。遵循这样的规范,有时人们能够从现有数据合理推断到涉及原因去除的情况。白血病骨髓移植的临床项目为讨论和说明这些观点提供了背景。生存研究中因删失导致的失效引发了进一步的讨论。

相似文献

1
The analysis of failure times in the presence of competing risks.存在竞争风险时的失效时间分析。
Biometrics. 1978 Dec;34(4):541-54.
2
Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.美国癌症协会关于空气污染颗粒与死亡率关系研究的长期随访及空间分析
Res Rep Health Eff Inst. 2009 May(140):5-114; discussion 115-36.
3
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.骨肉瘤患者的竞争风险分析:四种不同方法的比较。
Stat Med. 2001 Mar 15;20(5):661-84. doi: 10.1002/sim.711.
4
Hazard rate models with covariates.带有协变量的风险率模型。
Biometrics. 1979 Mar;35(1):25-39.
5
Simulating competing risks data in survival analysis.在生存分析中模拟竞争风险数据。
Stat Med. 2009 Mar 15;28(6):956-71. doi: 10.1002/sim.3516.
6
Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.基于累积发病率函数伪值的竞争风险数据回归建模
Biometrics. 2005 Mar;61(1):223-9. doi: 10.1111/j.0006-341X.2005.031209.x.
7
A missing data approach to semi-competing risks problems.一种用于半竞争风险问题的缺失数据方法。
Stat Med. 2007 Feb 20;26(4):837-56. doi: 10.1002/sim.2582.
8
Modelling competing risks in cancer studies.癌症研究中的竞争风险建模。
Stat Med. 2006 Mar 30;25(6):1015-34. doi: 10.1002/sim.2246.
9
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
10
"Just Another Statistic".“只是又一个统计数字”
Oncologist. 1998;3(3):III-IV.

引用本文的文献

1
Regression Modeling of Cumulative Incidence Function for Left-Truncated Right-Censored Competing Risks Data: A Modified Pseudo-observation Approach.左截断右删失竞争风险数据累积发病率函数的回归建模:一种改进的伪观测方法。
Commun Stat Theory Methods. 2025 Feb 11. doi: 10.1080/03610926.2025.2458183.
2
Set-Based Tests for Genetic Association Studies with Interval-Censored Competing Risks Outcomes.基于集合的区间删失竞争风险结局的基因关联研究检验
Stat Biosci. 2024 Jul 13. doi: 10.1007/s12561-024-09448-3.
3
Accounting for Competing Risks in the Assessment of Prognostic Biomarkers' Discriminative Accuracy.
在评估预后生物标志物的判别准确性时考虑竞争风险
Stat Biosci. 2025 Jul 7. doi: 10.1007/s12561-025-09499-0.
4
Multiscale Modeling of Hospital Length of Stay for Successive SARS-CoV-2 Variants: A Multi-State Forecasting Framework.连续新冠病毒变异株的医院住院时长多尺度建模:多状态预测框架
Viruses. 2025 Jul 6;17(7):953. doi: 10.3390/v17070953.
5
Multiple Imputation of Missing Covariates When Using the Fine-Gray Model.使用Fine-Gray模型时缺失协变量的多重填补
Stat Med. 2025 Jul;44(15-17):e70166. doi: 10.1002/sim.70166.
6
What Is the Survivorship of Megaprosthetic Reconstruction Following the Resection of Renal Cell Carcinoma Long Bone Metastases and What Are the Potential Risk Factors for a Prosthetic Complication?肾细胞癌长骨转移瘤切除术后大假体重建的生存率如何,假体并发症的潜在风险因素有哪些?
Cancers (Basel). 2025 Jun 13;17(12):1982. doi: 10.3390/cancers17121982.
7
Mixture mean residual life model for competing risks data with mismeasured covariates.具有测量误差协变量的竞争风险数据的混合平均剩余寿命模型
J Appl Stat. 2024 Nov 22;52(7):1361-1380. doi: 10.1080/02664763.2024.2426015. eCollection 2025.
8
Optimization of the Tacrolimus Concentration-to-Dose Ratio Cut-Off Value to Define Metabolism Groups.优化他克莫司浓度与剂量比值的截断值以定义代谢组。
J Clin Med. 2025 Apr 8;14(8):2542. doi: 10.3390/jcm14082542.
9
Causal Multistate Models to Evaluate Treatment Delay.用于评估治疗延迟的因果多状态模型
Stat Med. 2025 Mar 30;44(7):e70061. doi: 10.1002/sim.70061.
10
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.预测肾移植失败的竞争风险模型和非竞争风险模型
J Am Soc Nephrol. 2025 Apr 1;36(4):688-701. doi: 10.1681/ASN.0000000517. Epub 2024 Oct 16.